MPO and rheumatoid arthritis: Analysis of NETosis marker levels in patients depending on the disease stage revealed an increase in MPO in RA patients and mitochondrial cfDNA in PsA patients in the active stage of the disease compared with those in remission (Supplementary Table S19).